Navigation Links
Laser Capture Microdissection of muscle fiber populations and expression analysis by RT-PCR

acetylcholine esterase stain and their lack of slow MyHC staining (Figure 1C). MIFs were dissected based on their smaller neuromuscular junction and a positive signal for slow MyHC (Figure 1A). Additionally, muscle fibers were dissected which were positive or negative for slow MyHC, but didnt show a site of innervation based on Karnowsky and Rootss acetylcholine esterase stain. To dissect single fibers, it can be advantageous to search for fibers on the edge of a fiber bundle as they prove to be easier to dissect without picking up undesired fiber populations.


13. To avoid cross-contamination by other cell types, every cap is scanned visually after the dissection by placing the cap on a fresh slide and viewing it at lowest power. This is followed by a scan at the highest power to make sure that only the desired tissue was captured based on the fluorescence signal (Figures 1B and 1D). The cap is discarded, if unwanted tissue was present. Monochrome pictures of samples were taken using the QImaingTM Retiga 1300 cooled mono 12-bit digital camera.

14. Each cap is then placed in an ExtracSureTM device. The RNA from approximately 25 fibers of each population is pooled and RNA extraction is performed with the PicoPureTM RNA Isolation Kit as described in its protocol within 2 hours of the dehydration with xylenes.

15. After the RNA is extracted, the RiboAmpTM RNA Amplification Kit is used according to the manufacturers instructions to linearly amplify the sample RNA and transcribe the aRNA back to single stranded cDNA. One round of linear amplification was performed for all samples, typically yielding 300 - 600 ng of aRNA.

16. To study expression of muscle specific genes, 50 ng cDNA are amplified with FastStart Taq DNA Polymerase for 40 cycles with conditions and reagents as presented in Table I. The epsilon- and gamma- subunit of the a
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8

Related biology technology :

1. Isolate and Analyze Total RNA from Cells Harvested by Laser Capture Microdissection
2. Laser microdissection and nucleic acid purification - a Leica - QIAGEN cooperation
3. Working With Laser Capture Microdissection Samples
4. Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions
5. Laser Capture Microdissection (LCM) and Expression Profiling of Long-Range Projection Neurons
6. Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays
7. Laser Capture Microdissection of Cells Labeled with Enhanced Green Fluorescent Protein
8. Primary cells, rat heart muscle
9. High-throughput gene expression analysis to screen for anti-asthma drugs
10. Quantitative end-point RT-PCR gene expression measurement using the Agilent 2100 Bioanalyzer and standardized RT-PCR
11. Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives in the yeast Saccharomyces cerevisiae: Detection in vivo using the Varian Cary Eclipse
Post Your Comments:
Breaking Biology Technology:Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2